Michael A. Polis

12.8k citations

143 papers · 8.6k indexed · 2 hit papers · h-index 43

Impact in

Virology top 0.05%
- HIV Research and Treatment
Infectious Diseases top 0.2%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions

Papers in

Virology 60
- HIV Research and Treatment 60
Hepatology 47
- Hepatitis C virus research 44

Co-authors: Richard T. Davey Henry Masur Joseph A. Kovacs Julia A. Metcalf Judith Falloon H. Clifford Lane Robert Walker Robin Dewar
Journals: The Journal of Infectious Diseases (16 papers)AIDS (15 papers)Antimicrobial Agents and Chemotherapy (8 papers)AIDS Research and Human Retroviruses (7 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (5 papers)
Partner nations: United States Germany Netherlands

In The Last Decade

Michael A. Polis

140 papers receiving 8.4k citations

Hit Papers

align trajectories log scale

HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression 1999 · 639 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

1999 Proceedings of the National Academy of Sciences
1998 Nature

Peers

Countries citing papers authored by Michael A. Polis

Since Specialization

Citations

This map shows the geographic impact of Michael A. Polis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Polis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Polis more than expected).

Fields of papers citing papers by Michael A. Polis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Polis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Polis. The network helps show where Michael A. Polis may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Michael A. Polis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael A. Polis Line = papers co-authored together Michael A. Polis links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Establishing Reference Ranges of Hematological Parameters from Malian Healthy Adults PubMed ·Bourahima Kone, Mamoudou Maïga, Bocar Baya, Roger Bryant, Mette Wanning, R. A. Kovynev, Bassirou Diarra, M. Sanogo, S.P. Bhatt, D Goïta, 英世宮岡, Michael A. Polis, Camila Aguirre, Ракита Дмитрий Романович, Sounkalo Dao, Susan Orsega, Robert L. Murphy, Souleymane Diallo, Sophia Siddiqui	2017	15
2	High adherence to all-oral directly acting antiviral HCV therapy among an inner-city patient population in a phase 2a study Hepatology International ·Tess Petersen, Kerry Townsend, J. C. Zeltner, Sreetha Sidharthan, Rachel Silk, Amy Nelson, Chloe Gross, Ю.В. Владимиров, Michael A. Proschan, Anu Osinusi, Michael A. Polis, Henry Masur, Shyam Kottilil, Anita Kohli	2015	50
3	Short Communication: Serum-Based Assay Accurately Detects Single Nucleotide Polymorphisms of IL28B and SOCS3 in HIV/Hepatitis C Virus-Coinfected Subjects AIDS Research and Human Retroviruses ·Ashton A. Shaffer, Jon Hubbard, Kerry Townsend, Shyam Kottilil, Michael A. Polis, Henry Masur, Anita Kohli	2014	3
4	1 ALTERED HCV SPECIFIC T CELL IMMUNITY VERY EARLY IN INTERFERON FREE HCV DAA THERAPY Journal of Hepatology ·Lisa Feldman Barrett, M.P. Groth, D. Alman, Anu Osinusi, Anita Kohli, Eric G. Meissner, A. C. F. Beales, Amy Nelson, Michael A. Polis, Henry Masur, William T. Symonds, John McHutchinson, Shyam Kottilil	2013	13
5	Adjuvant Host-Directed Therapy with Types 3 and 5 but Not Type 4 Phosphodiesterase Inhibitors Shortens the Duration of Tuberculosis Treatment The Journal of Infectious Diseases ·Mamoudou Maïga, Nicole C. Ammerman, Mariama C. Maiga, Anatole Tounkara, Sophia Siddiqui, Michael A. Polis, Robert L. Murphy, William R. Bishai	2013	42
6	High interferon‐stimulated gene ISG‐15 expression affects HCV treatment outcome in patients co‐infected with HIV and HCV Journal of Medical Virology ·Antonios Katsounas, Jonathan J. Hubbard, Senaka Amarakeerthi, Xiaozhen Zhang, Diana R. Dou, Bhavana Shivakumar, Sophie L. Winter, JF Schlaak, Richard A. Lempicki, Henry Masur, Michael A. Polis, Shyam Kottilil, Anu Osinusi	2013	12
7	Dysregulation of innate immunity in hepatitis C virus genotype 1 IL28B -unfavorable genotype patients: Impaired viral kinetics and therapeutic response Hepatology ·Susanna Naggie, Anu Osinusi, Antonios Katsounas, Richard A. Lempicki, Eva Herrmann, Alexander Thompson, Paul J. Clark, Keyur Patel, Andrew J. Muir, John G. McHutchison, JF Schlaak, Martin Trippler, Bhavana Shivakumar, Henry Masur, Michael A. Polis, Shyam Kottilil	2012	55
8	ITPA gene polymorphisms significantly affect hemoglobin decline and treatment outcomes in patients coinfected with HIV and HCV Journal of Medical Virology ·Anu Osinusi, Susanna Naggie, Seerat Poonia, Martin Trippler, Zonghui Hu, Emily K. Funk, JF Schlaak, Dawn Fishbein, Henry Masur, Michael A. Polis, Shyam Kottilil	2012	12
9	Failure to Recognize Nontuberculous Mycobacteria Leads to Misdiagnosis of Chronic Pulmonary Tuberculosis PLoS ONE ·Mamoudou Maïga, Sophia Siddiqui, Souleymane Diallo, Bassirou Diarra, Min-Sung Kim, Yvonne R. Shea, Adrian M. Zelazny, Shileiko Va, D Goïta, Hang Thu Nguyen-Phung, Abdulrahman S. Hammond, Michael A. Polis, Anatole Tounkara	2012	98
10	Cumulative Viral Load and Virologic Decay Patterns after Antiretroviral Therapy in HIV-Infected Subjects Influence CD4 Recovery and AIDS PLoS ONE ·Vincent C. Marconi, Greg Grandits, Jason F. Okulicz, Glenn Wortmann, Anuradha Ganesan, Nancy F. Crum‐Cianflone, Michael A. Polis, Michael L. Landrum, Matthew J. Dolan, Sunil K. Ahuja, Brian K. Agan, Hemant Kulkarni	2011	43
11	Identification and Characterization of CRF02_AG, CRF06_cpx, and CRF09_cpx Recombinant Subtypes in Mali, West Africa AIDS Research and Human Retroviruses ·Hiromi Imamichi, Ousmane Koita, Djénéba Dabitao, Cordero Aguilar Yanislet, Cecilia Veronica Albor Parada, CAROLYNN TALLEY, Robin Dewar, 欧阳红波, Mitsuo Ishibashi, Mark Parta, Aaron Holm, Michael A. Polis, H. Clifford Lane, Anatole Tounkara	2009	11
12	Rapid Development of Advanced Liver Fibrosis after Acquisition of Hepatitis C Infection during Primary HIV Infection AIDS Patient Care and STDs ·Anu Osinusi, David E. Kleiner, Bradford J. Wood, Michael A. Polis, Henry Masur, Shyam Kottilil	2009	7
13	Predictors for Hematopoietic Growth Factors Use in HIV/HCV-Coinfected Patients Treated with Peginterferon Alfa 2b and Ribavirin AIDS Patient Care and STDs ·Alice K. Pau, 彰松村, Zonghui Hu, V.I. Cherkis, Michael A. Polis, Shyam Kottilil	2006	6
14	Extensive Retinal Neovascularization as a Late Finding in Human Immunodeficiency Virus–Infected Patients with Immune Recovery Uveitis Clinical Infectious Diseases ·Mary E. Wright, Daniel L. Suzman, Karl G. Csaky, Henry Masur, Michael A. Polis, Michael R. Robinson	2003	18
15	Peripheral Choroidal Neovascularization as a Late Finding in HIV-infected Patients with Inactive Cytomegalovirus Retinitis and Ocular Inflammation from Immune Recovery Uveitis Investigative Ophthalmology & Visual Science ·Wilson Fernando García Castellanos, Nancy Hoehman, K.G. Csaky, Henry Masur, Michael A. Polis, Robinson	2002	0
16	Interleukin-2 induced immune effects in human immunodeficiency virus-infected patients receiving intermittent interleukin-2 immunotherapy European Journal of Immunology ·Joseph A. Kovacs, Susan Vogel, WonJae, LI Shuang-tia, Randy Stevens, Joseph W. Adelsberger, Richard A. Lempicki, Richard L. Hengel, Irini Sereti, Sholikatun Nikmah, Robin Dewar, Richard T. Davey, Robert Walker, J Falloon, Michael A. Polis, Henry Masur, H. Clifford Lane	2001	48
17	Effects of Intermittent Interleukin‐2 Therapy on Plasma and Tissue Human Immunodeficiency Virus Levels and Quasi‐Species Expression The Journal of Infectious Diseases ·Joseph A. Kovacs, Hiromi Imamichi, Susan Vogel, Julia A. Metcalf, Robin Dewar, Michael Baseler, Randy Stevens, Joseph W. Adelsberger, Laurie Lambert, Richard T. Davey, Robert Walker, Judith Falloon, Michael A. Polis, Henry Masur, H. Clifford Lane	2000	25
18	Induction of humoral and cell-mediated anti-human immunodeficiency virus (HIV) responses in HIV sero-negative volunteers by immunization with recombinant gp160. Journal of Clinical Investigation ·Joseph A. Kovacs, M. B. Vasudevachari, E Mandt Kathleen, Richard T. Davey, Judith Falloon, Michael A. Polis, Julia A. Metcalf, Norman P. Salzman, Michael Baseler, Gale Smith	1993	32
19	Phase I/II Studies of the Toxicity and Immunogenicity of Recombinant gp160 and p24 Vaccines in HIV-Infected Individuals AIDS Research and Human Retroviruses ·Kathryn M. Zunich, H. Clifford Lane, Richard T. Davey, J Falloon, Michael A. Polis, Joseph A. Kovacs, Henry Masur	1992	6
20	Design of a randomized controlled trial of foscarnet in patients with cytomegalovirus retinitis associated with acquired immunodeficiency syndrome The American Journal of Medicine ·Michael A. Polis	1992	2

About Michael A. Polis

Michael A. Polis is a scholar working on Virology, Hepatology, Infectious Diseases, Epidemiology and Emergency Medicine, having authored 143 papers that have together received 8.6k indexed citations. Recurring topics across this work include HIV Research and Treatment (60 papers), HIV/AIDS drug development and treatment (47 papers), Hepatitis C virus research (44 papers), HIV/AIDS Research and Interventions (32 papers), Cytomegalovirus and herpesvirus research (24 papers), Hepatitis B Virus Studies (22 papers), Pneumocystis jirovecii pneumonia detection and treatment (18 papers) and Liver Disease Diagnosis and Treatment (17 papers). The work is most often cited by research in Virology (4.3k citations), Infectious Diseases (3.5k citations), Immunology (2.8k citations), Hepatology (930 citations) and Emergency Medicine (832 citations). Michael A. Polis has collaborated with scholars based in United States, Germany and Netherlands. Frequent co-authors include Richard T. Davey, Henry Masur, Joseph A. Kovacs, Julia A. Metcalf, Judith Falloon, H. Clifford Lane, Robert Walker, Robin Dewar, Mark B. Feinberg and Michael Baseler. Their work appears in journals such as The Journal of Infectious Diseases, AIDS, Antimicrobial Agents and Chemotherapy, AIDS Research and Human Retroviruses and JAIDS Journal of Acquired Immune Deficiency Syndromes.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact